Zusammenfassung
Das Problem der Labordiagnostik ist in jedem Fachgebiet der Medizin aktuell. So stellt sich häufig die Frage, welche Laboruntersuchungen bei welcher Krankheit sinnvoll sind und in welchem Labor neuere Spezialuntersuchungen durchgeführt werden können.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Practice parameter for diagnosis and evaluation of dementia. (summary statement) Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 44(11):2203–2006, 1994 Nov
Bachman DL, Wolf PA, Linn R, Knoefel JE, Cobb J, Belanger A, D’Agostino RB, White LR (1992) Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology 42(1):115–119
Wells CE (1978) Chronic brain disease: an overview. Am J Psychiatry 135(1):1–12
Buch K, Riemenschneider M, Bartenstein P Willoch F, Mueller U, Schmolke M, Nolde T, Steinmann C, Guder WG, Kurz A (1998) Tau-Protein: Ein potentieller biologischer Indikator zur Früherkennung der Alzheimer-Krankheit Nervenarzt 69(5):379–385
Awad AG (1986) The Thyroid and the Mind and Emotions/Thyroid Dysfunction and Mental Disorders. Thyrobulletin 7 (3)
Leo RJ, Bottermann-Fauce JM, Pickhardt D, Cartagena M, Cohen G (1997) Utility of thyroid function screening in adolescent psychiatric inpatients. J Am Acad Child Adolesc Psychiatry 36(1):103–111
Bauer J (1994) Klinische Diagnostik and Therapiemöglichkeiten der Demenz vom Alzheimer-Typ. Fortschr Neurol Psychiatr 62(11):417–432
Zubenko GS, Winwood E, Jacobs B, Teply I, Stiffler JS, Hughes HB 3rdHuff FJ, Sunderland T, Martinez AJ (1999) Prospective study of risk factors for Alzheimer’s disease: results at 7.5 years. Am J Psychiatry 156(1):50–57
Slooter AJ, Cruts M, Kalmijn S, Holman A, Breteler MM, van Broeckhoven C, van Duijn CM (1998) Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol 55(7):964–968
Mayeux R, Saunders AM, Shea S, Mirra S, Evans D, Roses AD, Hyman BT, Crain Bl (1998) Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer’s disease. N Engl J Med 338(8):506–511
Growdon JH (1999) Biomarkers of Alzheimer Disease. Arch Neurol 56(3):281–283
Sunderland T et al (1999) Longitudinal stability of CSF tau levels in Alzheimer patients. Biol Psychiatry 46(6):750–755
Andreasen N et al (1999) Sensitivity, spezificity, and stability of CSF-tau in AD in a community-based patient sample. Neurology 53(7):1488–1494
Andreasen N, Hesse C, Davidsson P, Minthon L, Wallin A, Winblad B, Vanderstichele H, Vanmechelen E, Blennow K (1999) Cerebrospinal fluid beta-amyloid(1–42) in Alzheimer disease: differences between early-and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol 56(6):673–680
Hulstaert F, Blennow K, Ivanoiu A, Schoonderwaldt HC, Riemenschneider M, De Deyn PP, Bancher C, Cras P, Wiltfang J, Mehta PD, Iqbal K, Pottel H, Vanmechelen E, Vanderstichele H (1999) Improved discrimination of AD patients using beta-amyloid(1–42) and tau levels in CSF. Neurology 52(8):1555–1562
Jensen M, Schroeder J, Blomberg M, Engvall B, Pantel J, Ida N, Basun H, Wahlund LO, Werle E, Jauss M, Beyreuther K, Lannfelt L, Hartmann T (1999) Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer’s disease and declines with disease progression. Ann Neurol 45(4):504–511
Monte SM, Ghanbari K, Frey WH, Beheshti I, Averback IP, Hauser SL, Ghanbari HA, Wands JR (1997) Characterization of the AD7C-NTP cDNA expression in Alzheimer’s disease and measurement of a 41-kD protein in cerebrospinal fluid. J Clin Invest 100(12):3093–3104
Ackermann H (1998) Demenz. In: Brandt T, Dichgans J, Diener HC (Hrsg) Therapie and Verlauf neurologischer Erkrankungen. Kohlhammer: Stuttgart, Berlin, Köln
Fallon BA, Nieds JA, Burrascano JJ, Liegner K, DelBene D, Liebowitz MR (1992) The neuropsychiatric manifestations of Lyme Borreliosis. Psychiatr Q 63(1):95–117
Fallon BA, Schwartzberg M, Bransfield R, Zimmerman B, Scotti A, Webber C, Liebowitz M (1995) Late-stage neuropsychiatric Lyme Borreliosis differential diagnosis and treatment. Psychosomatics 36: 295–300
Fallon BA, Nields JA, Parson B, Liebowitz MR, Klein DF (1993) Psychiatric manifestations of Lyme Borreliosis. J Clin Psychiatry 54(7):263–268
Voelker R (1989) Separating symptoms from Hysteria. Am Med News 22(29):9–11
Loggian EL et al (1990) Chronic neurologic manifestations of Lyme Disease. N Engl J Med 323:1438–1444
Pfister HW et al (1993) Catatonic syndrome in acute severe encephalitis due to Borrelia burgdorferi infection. Neurology 43:433–435
Ackermann R et al (1989) Chronic neurologic manifestations of Erythema migrans borreliosis. Ann N Y Acad Sci 539:16–23
Halperin JJ, Pass HL, Anand AK, Luft BJ, Volkman DJ, Dattwyler RJ (1988) Nervous system abnomalities in Lyme Disease. Ann N Y Acad Sci 539:24–34
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Wien
About this paper
Cite this paper
Petereit, K., Peter, K. (2002). Probleme der Labordiagnostik in der Psychiatrie — ausgewählte Aspekte. In: Peter, K. (eds) Fortschritte in Psychiatrie und Psychotherapie. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6169-2_15
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6169-2_15
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83557-9
Online ISBN: 978-3-7091-6169-2
eBook Packages: Springer Book Archive